NICM Health Research Institute's Associate Professor Mike Amour is leading a number of medicinal cannabis studies in endometriosis and other gynaecological and menstrual conditions.
The multidisciplinary projects will involve academics, researchers, medical professionals and endometriosis advocates from Western Sydney University, Deakin University, Macquarie University, University of Tasmania, UNSW Sydney, the University of Sydney, the Medical Research Institute of New Zealand, Royal Hospital for Women in Randwick, Endometriosis Australia and the National Endometriosis Clinical and Scientific Trials Network.
Currently planned are two separate randomised controlled trials looking at the effect of various types of medicinal cannabis on endometriosis. One trial will be conducted in Sydney, and the other in Victoria. Preclinical studies are also planned that will look at how medicinal cannabis can affect things like blood flow in various parts of the body including to the uterus.
We expect the first of these clinical studies to start by May 2023.